Elixxer Announces Adoption of Semi-Annual Reporting

Elixxer Provides Update on Secured and Unsecured Loans

Elixxer Announces Completion of Debt Settlement

Elixxer Announces Results of Annual and Special Meeting of Shareholders

Elixxer Ltd. Provides Update and Corrective Statements on Proposed Debt Settlement and Upcoming Shareholder Meeting

Elixxer Ltd. Announces Debt Settlement

Elixxer Ltd. Announces Proposed Shares for Debt Settlements

Elixxer Provides Corporate Update

Elixxer Announces Bridge Loan

Elixxer Ltd.: Revocation of Cease Trade Order

Elixxer Announces Results of Annual and Special Meeting of Shareholders

Elixxer Announces Appointment of Edward Milewski as a Director

Elixxer Announces Appointment of Mark Romano as a Director

Elixxer Announces Appointment of Fiona Fitzmaurice as Chief Financial Officer

Elixxer Announces Appointment of Karim Mecklai as Chief Executive Officer

Elixxer Announces Intention to Consolidate its Common Shares

Elixxer Announces Approval of Share Buyback

Elixxer's Largest Holding, Little Green Pharma, Completes Transformational Quarter

Elixxer Announces Intention to Make Normal Course Issuer Bid

Elixxer Ltd. Announces Amendment to Proposed Debt Settlement Transactions

Elixxer Ltd. Announces Revised Debt Settlement Transactions

Elixxer Ltd. Provides Corporate Update